ClinVar Miner

Submissions for variant NM_014000.3(VCL):c.1607C>A (p.Pro536His)

gnomAD frequency: 0.00004  dbSNP: rs200624351
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000172504 SCV000051358 uncertain significance not provided 2013-06-24 criteria provided, single submitter research
Illumina Laboratory Services, Illumina RCV001089302 SCV000364929 uncertain significance Dilated cardiomyopathy 1W 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001089302 SCV000645844 likely benign Dilated cardiomyopathy 1W 2023-12-22 criteria provided, single submitter clinical testing
GeneDx RCV000172504 SCV001759569 uncertain significance not provided 2020-10-02 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar, but additional evidence is not available (ClinVar Variant ID# 192105; Landrum et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function
Ambry Genetics RCV004678624 SCV005179529 uncertain significance Cardiovascular phenotype 2024-05-20 criteria provided, single submitter clinical testing The p.P536H variant (also known as c.1607C>A), located in coding exon 12 of the VCL gene, results from a C to A substitution at nucleotide position 1607. The proline at codon 536 is replaced by histidine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.